Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
EMHJ-Eastern Mediterranean Health Journal. 2018; 24 (02): 198-215
in English | IMEMR | ID: emr-190342

ABSTRACT

Background: According to World Health Organization [WHO] reports, the prevalence of smoking is increasing in many developing countries, including Egypt. The aim of this study is to summarize the published data in the literature about tobacco smoking in Egypt. Methods: A computerized literature search of PubMed and relevant Egyptian journals was conducted using the relevant keywords. The findings of retrieved studies were extracted and discussed in a narrative approach. Results: Our search retrieved 44 relevant studies. The most updated prevalence of tobacco smoking in Egypt is 22% in 2010 and is increasing. Highly significant odds ratios were reported for sibling, parent, and peer smoking as risk factors for smoking. Cardiovascular disorders, malignant tumors, and erectile dysfunction are common complications of smoking in the Egyptian population. Efforts to control tobacco smoking are available, but inadequate. Conclusions: Tobacco smoking is a prevalent health problem in Egypt, associated with cardiovascular disorders and malignant tumors. Health education programmes should be delivered through mass media and school-based programmes to reach a large section of the Egyptian population


Subject(s)
Humans , Male , Female , Risk Factors , Cardiovascular Diseases , Tobacco Use , Cross-Sectional Studies , Prevalence , Smoking/epidemiology
2.
The Korean Journal of Pain ; : 176-182, 2017.
Article in English | WPRIM | ID: wpr-64617

ABSTRACT

BACKGROUND: Current evidence suggests that intravenous magnesium sulfate might be effective for reducing migraine pain. In a recent pilot study, we showed that intravenous caffeine citrate could reduce the severity of migraine headache. The objective of this study is to investigate the efficacy of intravenous caffeine citrate vs. magnesium sulfate for management of acute migraine headache. METHODS: We conducted a prospective quasi-experimental study from January until May 2016 in two educational medical centers of Shahid Beheshti University of Medical Sciences (Shoahadaye Tajrish Hospital and Imam Hossein Hospital), Tehran, Iran. The study included patients who were referred to the emergency department and met the migraine diagnosis criteria of the International Headache Society. Patients were allocated into 2 groups receiving either 60 mg intravenous caffeine or 2 g intravenous magnesium sulfate. The pain scores, based on the visual analog scale, were recorded on admission, as well as one and two hours after receiving the drug. A Chi-Square test and student t-test were used for analysis of baseline characteristics. A Mann-Whitney U test and Wilcoxon singed rank test were used to analyze differences in the visual analogue scale (VAS) score between and within the groups respectively. RESULTS: In total, 70 patients (35 patients in each group) with the mean age of 33.1 ± 11.3 years were included (64.3% female). For the Caffeine citrate group, the median pain score decreased from 9.0 (2.0) to 5.0 (4.0) after one hour and to 3.0 (4.0) after two hours. For the magnesium sulfate group, the pain score decreased from 8.0 (2.0) to 2.0 (2.0) after one hour and to 0.0 (1.0) after two hours. Both intravenous caffeine citrate and intravenous magnesium sulfate reduced pain scores significantly but the magnesium sulfate group showed more improvement than the Caffeine citrate group after one hour (P < 0.001) and after two hours (P < 0.001). CONCLUSIONS: It is likely that both intravenous caffeine and intravenous magnesium sulfate can reduce the severity of migraine headache. Moreover, intravenous magnesium sulfate at a dose of 2 g might be superior to intravenous caffeine citrate 60 mg for the short term management of migraine headache in emergency departments.


Subject(s)
Humans , Caffeine , Citric Acid , Clergy , Diagnosis , Emergency Service, Hospital , Headache , Iran , Magnesium Sulfate , Magnesium , Migraine Disorders , Non-Randomized Controlled Trials as Topic , Pain Management , Pilot Projects , Prospective Studies , Visual Analog Scale
3.
Emergency Journal. 2015; 3 (4): 170-171
in English | IMEMR | ID: emr-170870

ABSTRACT

In the previous two parts of educational manuscript series in Emergency, we explained some screening characteristics of diagnostic tests including accuracy, sensitivity, specificity, and positive and negative predicative values [1, 2]. In the 3rd part we aimed to explain positive and negative likelihood ratio [LR] as one of the most reliable performance measures of a diagnostic test [3]. To better understand this characteristic of a test, it is first necessary to fully understand the concept of sensitivity and specificity. So we strongly advise you to review the 1st part of this series again [1, 2]. In short, the likelihood ratios are about the percentage of people with and without a disease but having the same test result [4]. The prevalence of a disease can directly influence screening characteristics of a diagnostic test, especially its sensitivity and specificity. Trying to eliminate this effect, LR was developed. Pre-test probability of a disease multiplied by positive or negative LR can estimate post-test probability. Therefore, LR is the most important characteristic of a test to rule out or rule in a diagnosis. A positive likelihood ratio > 1 means higher probability of the disease to be present in a patient with a positive test. The further from 1, either higher or lower, the stronger the evidence to rule in or rule out the disease, respectively [5]. It is obvious that tests with LR close to one are less practical. On the other hand, LR further from one will have more value for application in medicine. Usually tests with LR < 0.1 or > 10 are considered suitable for implication in routine practice

4.
Emergency Journal. 2015; 3 (3): 87-88
in English | IMEMR | ID: emr-170872

ABSTRACT

In volume 3, number 2, pages 48-49, we explained some screening characteristics of a diagnostic test in an educational manuscript entitled "Simple definition and calculation of accuracy, sensitivity and specificity" [1]. The present article was aimed to review other screening performance characteristics including positive and negative predictive values [PPV and NPV]. PPV and NPV are true positive and true negative results of a diagnostic test, respectively [2]. In other words, if a subject receives a certain diagnosis by a test, predictive values describe how likely it is for the diagnosis to be correct

SELECTION OF CITATIONS
SEARCH DETAIL